Cannabis and the psychedelics: Reviewing the UN drug conventions

2Citations
Citations of this article
13Readers
Mendeley users who have this article in their library.
Get full text

Abstract

The current international prohibitionist approach to the regulation of psychoactive drugs causes serious harms. It creates an illicit market that is responsible for conflict and corruption; denies medication to the world's poorest; and impedes scientific research into the potential benefits of psychoactive substances. Moreover, it undermines the personal and societal benefit of allowing people to do things that they value, so long as they do not harm others. At the heart of the problem lie the three UN Drug Conventions, which mandate a one-size-fits-all criminalizing approach on all parties. The work of the Beckley Foundation's Global Cannabis Commission, and a new Beckley Foundation Report on reforming the UN Drug Conventions, spell out how countries-acting alone or, better, in concert with other like-minded nations-could work within the framework of international law in order to implement drug policies that better meet their own special needs and circumstances. Recent initiatives for reform, emanating mostly from the drug-producing and transit countries of Latin America, provide encouraging signs that progress is within our grasp.

Cite

CITATION STYLE

APA

Feilding, A. (2013). Cannabis and the psychedelics: Reviewing the UN drug conventions. In Prohibition, Religious Freedom, and Human Rights: Regulating Traditional Drug Use (pp. 189–210). Springer-Verlag Berlin Heidelberg. https://doi.org/10.1007/978-3-642-40957-8_10

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free